Breath-based Sensor for Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to determine whether an array of biosensors can noninvasively identify hyperglycemic or hypoglycemic events in persons diagnosed with diabetes through noninvasive detection of volatile organic compounds (VOCs) in exhaled breath.
Who Is on the Research Team?
Linda DiMeglio, MD
Principal Investigator
Indiana University
Mark Woollam, PhD
Principal Investigator
Indiana University
Are You a Good Fit for This Trial?
This trial is for people diagnosed with diabetes who may experience high or low blood sugar. Participants should be able to provide breath samples and follow study instructions.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Sensing Device
Trial Overview
Researchers are testing a small, noninvasive breath sensor that collects exhaled air in special bags to see if it can detect episodes of high or low blood sugar by analyzing chemicals in the breath.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants diagnosed with type 1 diabetes (T1D) or type 2 diabetes (T2D) will be recruited for the study. Following consent, enrolled subjects will donate breath samples for approximately one week over the course of the summer camp. Each subject will donate two breath samples during at least n = 15 breath collection events (n = 30 samples in total) for analysis by sensors and gas chromatography-mass spectrometry (GC-MS), while also collecting finger stick data right before (or after) each breath sample. The participant will also wear a CGM as a routine standard care procedure for diabetes management.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.